NOVO NORDISK INC. et al v. SANDOZ INC.
| NOVO NORDISK INC. and NOVO NORDISK A/S |
| SANDOZ INC. |
| 3:2020cv06842 |
| June 4, 2020 |
| US District Court for the District of New Jersey |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 4, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 3 Corporate Disclosure Statement by NOVO NORDISK A/S identifying None as Corporate Parent.. (CHEVALIER, CHARLES) |
| Filing 2 Corporate Disclosure Statement by NOVO NORDISK INC. identifying Novo Nordisk A/S as Corporate Parent.. (CHEVALIER, CHARLES) |
| Filing 1 COMPLAINT against SANDOZ INC. ( Filing and Admin fee $ 400 receipt number ANJDC-10900382), filed by NOVO NORDISK INC., NOVO NORDISK A/S. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Exhibit E, #6 Exhibit F, #7 Civil Cover Sheet, #8 Certification Pursuant to Local Civil Rule 11.2)(CHEVALIER, CHARLES) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
